RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/42AD615C886D25CB820F5CD09662010019543109D6D9EA19BF2931D3A2DC6A9F8E83C6B64A17883476CEA51729AC4A58http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/42AD615C886D25CB820F5CD09662010019543109D6D9EA19BF2931D3A2DC6A9F8E83C6B64A17883476CEA51729AC4A58http://www.w3.org/2000/01/rdf-schema#comment"The three patients had different novel compound heterozygous mutations in IFT122. Consequently we compared these three patients to those previously described with IFT122 mutations. Thus our report serves to add 6 novel mutations to the IFT122 mutation spectrum and to contribute to the IFT122-related clinical characterization."xsd:string
http://purl.uniprot.org/uniprot/#_0374A1A431143D6A0D701E26A9F6E30208EEBC17CBBD3C58813A13488C07226F3E99E290FF50D7F1978B35175E2CCF2Ahttp://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/42AD615C886D25CB820F5CD09662010019543109D6D9EA19BF2931D3A2DC6A9F8E83C6B64A17883476CEA51729AC4A58
http://purl.uniprot.org/uniprot/B3KUD1http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/42AD615C886D25CB820F5CD09662010019543109D6D9EA19BF2931D3A2DC6A9F8E83C6B64A17883476CEA51729AC4A58
http://purl.uniprot.org/uniprot/#_B3KUD1-mappedCitation-26792575http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/42AD615C886D25CB820F5CD09662010019543109D6D9EA19BF2931D3A2DC6A9F8E83C6B64A17883476CEA51729AC4A58